This report provides insight into the current market scenario, structure and practices.

Market landscape and market scenario includes:

> Current market size estimate
> Revenues by players - Top 5 Companies
> Market size by product categories
> Market size by regions/country

Market structure details the value chain, Players? presence across products, market trends, distribution practices and pricing.

The report also provides a snapshot of key competition, past market trends with forecast over the next 5 years, anticipated growth rates and the principal factors driving and impacting growth

Analysis and market data has been derived through secondary and primary sources.

Segmentation in the report
By Product:
1. Recombinant Therapeutic Proteins
1.1. Monoclonal Antibodies
1.2. Hormones
1.3. Cytokines
1.4. Enzymes
2. Blood & Blood components
3. Cellular & Gene Therapy
4. Vaccines

By Disease:
1. Oncology
1.1. Breast Cancer
1.2. Leukemia
1.3. Ovarian Cancer
1.4. Non-Hodgkin Lymphoma
1.5. Prostate Cancer
1.6. Colorectal Cancer
1.7. Others (bladder cancer, lung cancer, etc.)
2. Autoimmune diseases
2.1. Systemic Sclerosis
2.2. Crohn?s Disease
2.3. Rheumatoid arthritis
2.4. Systemic Lupus Erythematous
2.5. Others (Sjogren's syndrome, multiple sclerosis, pernicious anemia, etc.)
3. Diabetes
4. Infectious diseases
5. Others

Companies covered in the report are:
1. Merck & Co. Inc.
2. AbbVie, Inc.
3. AstraZeneca Plc.
4. Amgen, Inc.
5. Celgene Corporation
6. Bristol-Myers Squibb Co.
7. Eli Lilly and Company
8. Janssen Pharmaceuticals, Inc.
9. GlaxoSmithKline Plc.
10. Novartis AG
11. Pfizer, Inc.
12. Novo Nordisk A/S